209 related articles for article (PubMed ID: 37393293)
1. Landscape of PCOS co-expression gene and its role in predicting prognosis and assisting immunotherapy in endometrial cancer.
Zhang Y; Hu Y; Yu J; Xie X; Jiang F; Wu C
J Ovarian Res; 2023 Jul; 16(1):129. PubMed ID: 37393293
[TBL] [Abstract][Full Text] [Related]
2. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
3. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients.
Jiang F; Luo F; Zeng N; Mao Y; Tang X; Wang J; Hu Y; Wu C
Front Immunol; 2022; 13():902143. PubMed ID: 35903107
[TBL] [Abstract][Full Text] [Related]
6. The combined signatures of G protein-coupled receptor family and immune landscape provide a prognostic and therapeutic biomarker in endometrial carcinoma.
Chen S; Luo X; Yang B; Zhuang J; Guo J; Zhu Y; Mo J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14701-14719. PubMed ID: 37584707
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas.
Alqutami F; Hachim M; Hodgman C; Atiomo W
Oncotarget; 2023 Sep; 14():825-835. PubMed ID: 37737665
[TBL] [Abstract][Full Text] [Related]
8. Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?
Shafiee MN; Chapman C; Barrett D; Abu J; Atiomo W
Gynecol Oncol; 2013 Nov; 131(2):489-92. PubMed ID: 23822891
[TBL] [Abstract][Full Text] [Related]
9. A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining.
Huang H; Cai X; Lin J; Wu Q; Zhang K; Lin Y; Liu B; Lin J
Comput Biol Med; 2023 Mar; 155():106632. PubMed ID: 36805217
[TBL] [Abstract][Full Text] [Related]
10. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
[TBL] [Abstract][Full Text] [Related]
11. Identification of immunogenic cell death-related subtypes used for predicting survival and immunotherapy of endometrial carcinoma through a bioinformatics analysis.
Liu Z; Luo Y; Su L; Hu X
Medicine (Baltimore); 2023 Aug; 102(31):e34571. PubMed ID: 37543760
[TBL] [Abstract][Full Text] [Related]
12. A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs.
Wang M; An K; Huang J; Mprah R; Ding H
Front Endocrinol (Lausanne); 2023; 14():1193992. PubMed ID: 37745699
[TBL] [Abstract][Full Text] [Related]
13. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment CD8 T and Treg Cells-related Genes Signature Distinguishes Distinct Prognosis and Targeted Therapies Response in Endometrial Cancer.
Liu X; Feng D; Wang W; Liang J; Yu H; Ling B
J Immunother; 2023 Jun; 46(5):178-191. PubMed ID: 37098928
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
Yang L; Cui Y; Sun X; Wang Y
Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
Cheng P; Ma J; Zheng X; Zhou C; Chen X
Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
[TBL] [Abstract][Full Text] [Related]
17. Exploration of molecular features of PCOS with different androgen levels and immune-related prognostic biomarkers associated with implantation failure.
Gao Q; Ma C; Meng S; Wang G; Xing Q; Xu Y; He X; Wang T; Cao Y
Front Endocrinol (Lausanne); 2022; 13():946504. PubMed ID: 36060967
[TBL] [Abstract][Full Text] [Related]
18. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
20. BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.
Liu J; Tian T; Liu X; Cui Z
J Immunol Res; 2022; 2022():6051092. PubMed ID: 35915658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
